Testing effectiveness (Phase 2)Looking for participantsNCT06526819What this trial is testingSMP-3124LP in Adults With Advanced Solid TumorsWho this might be right forSolid Tumor Sumitomo Pharma America, Inc. 120
Early research (Phase 1)Ended earlyNCT03957096What this trial is testingA Safety Study of SGN-CD47M in Patients With Solid TumorsWho this might be right forSoft Tissue SarcomaColorectal CancerHead and Neck Squamous Cell Carcinoma+6 more Seagen Inc. 16
Testing effectiveness (Phase 2)Study completedNCT02799095What this trial is testingThe Effects of ALKS 4230 (Nemvaleukin Alfa) on Subjects With Solid TumorsWho this might be right forAdvanced Solid Tumors Mural Oncology, Inc 243
Early research (Phase 1)Ended earlyNCT04999202What this trial is testingLearn How Safe the Study Drug BAY 2416964 (AhR Inhibitor) in Combination With the Treatment Pembrolizumab is, How This Combination Affects the Body, the Maximum Amount That Can be Given, How it Moves Into, Through and Out of the Body and Its Action Against Advanced Solid Cancers in AdultsWho this might be right forAdvanced Solid Tumors Bayer 47
Testing effectiveness (Phase 2)Looking for participantsNCT05269381What this trial is testingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more Mayo Clinic 138
Testing effectiveness (Phase 2)UnknownNCT05044728What this trial is testingExploration of Immunodynamic Monitoring in the Population Evaluation of Neoadjuvant Chemotherapy Immunotherapy in Patients With Solid Tumors of the Chest.Who this might be right forNon-small Cell Lung CancerEsophageal Squamous Cell Carcinoma Sichuan Cancer Hospital and Research Institute 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT03476681What this trial is testingStudy of NEO-201 in Solid Tumors Expansion CohortsWho this might be right forNon Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaCervical Cancer+1 more Precision Biologics, Inc 121
Early research (Phase 1)Ended earlyNCT03621982What this trial is testingStudy of ADCT-301 in Patients With Selected Advanced Solid TumorsWho this might be right forHead and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more ADC Therapeutics S.A. 78
Testing effectiveness (Phase 2)Looking for participantsNCT05267626What this trial is testingStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic CancerWho this might be right forAdvanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more Aulos Bioscience, Inc. 159
Testing effectiveness (Phase 2)Active Not RecruitingNCT04152499What this trial is testingPhase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)Who this might be right forEpithelial Ovarian CancerGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+7 more Klus Pharma Inc. 1,410
Early research (Phase 1)Ended earlyNCT02952989What this trial is testingA Safety Study of SGN-2FF for Patients With Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small-Cell LungCarcinoma, Renal CellBreast Neoplasms+5 more Seagen Inc. 47
Testing effectiveness (Phase 2)Study completedNCT03989115What this trial is testingDose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLCWho this might be right forSolid Tumor Revolution Medicines, Inc. 113
Early research (Phase 1)Active Not RecruitingNCT06238479What this trial is testingLY4101174 in Participants With Recurrent, Advanced or Metastatic Solid TumorsWho this might be right forMetastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more Eli Lilly and Company 490
Early research (Phase 1)Active Not RecruitingNCT05277051What this trial is testingFirst-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid TumorsWho this might be right forNeoplasms GlaxoSmithKline 152
Early research (Phase 1)Not Yet RecruitingNCT07807956What this trial is testingAssess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsNon-Small Cell Lung CancerColorectal Cancer+6 more AbbVie 130
Post-approval studies (Phase 4)Looking for participantsNCT07405086What this trial is testingMorning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT StudyWho this might be right forAdvanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more OHSU Knight Cancer Institute 160
Early research (Phase 1)Study completedNCT02635672What this trial is testingPhase I Dose Escalation Study for VIP152 in Patients With Advanced CancerWho this might be right forNeoplasms Vincerx Pharma, Inc. 110
Testing effectiveness (Phase 2)Looking for participantsNCT07169734What this trial is testingInvestigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid TumorsWho this might be right forCervical Squamous Cell CarcinomaSquamous Non-small-cell Lung CancerColorectal Cancer+2 more Alentis Therapeutics AG 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT04180371What this trial is testingStudy BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 ExpressionWho this might be right forAdvanced Solid Tumor Historically Known for High EphA2 ExpressionUrothelial CancerOvarian Cancer+4 more BicycleTx Limited 288
Testing effectiveness (Phase 2)Study completedNCT01204099What this trial is testingStudy of PX-866 and Docetaxel in Solid TumorsWho this might be right forNon Small Cell Lung Cancer (NSCLC)Squamous Cell Carcinoma of the Head and Neck (SCCHN) Cascadian Therapeutics Inc. 223